Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
4
Jiayu Holding
300117
5
Wuxi Taclink Optoelectronics Technology
688205
CN Stock MarketDetailed Quotes
688443 Chongqing Genrix Biopharmaceutical
- 24.57
- -0.26-1.05%
Market Closed Jan 22 15:00 CST
9.01BMarket Cap-11.56P/E (TTM)
25.12High24.25Low10.58KlotVolume24.99Open24.83Pre Close25.96MTurnover0.93%Turnover RatioLossP/E (Static)366.68MShares45.5152wk High3.83P/B2.80BFloat Cap22.1152wk Low29.80Limit Up114.04MShs Float45.51Historical High19.86Limit Down3.50%Amplitude22.11Historical Low--Dividend TTM24.54Avg Price5.09KlotAsk--Div YieldTTM100Lot Size4.46KlotBid
About Chongqing Genrix Biopharmaceutical Company
The company was founded in 2015 and is located in Chongqing International Biotechnology City. It is an innovative biopharmaceutical company driven by antibody drug discovery technology, focusing on treatment fields such as autoimmune diseases, infectious diseases, and tumors, and is engaged in R&D, production and commercialization of antibody drugs. The company's main business is R&D, production and sales of antibody drugs. The company's main products are Celizumab (GR1501), GR1802, GR1603, GR1801, GR2001, GR1803, etc. Company honors: Chongqing's “Specialized, Special and New” Enterprise, Big Data Application Demonstration Enterprise, Zhongtiancoin High-tech Enterprise, etc.
Company Profile
Short Name-A智翔金泰
Company NameChongqing Genrix Biopharmaceutical Co., Ltd.
Listing DateJun 20, 2023
Issue Price37.88
Shares Offered91.68M share(s)
FoundedOct 20, 2015
Chairmanzhigang liu
Legal Representativezhigang liu
General Managerzhigang liu
Secretarychunsheng li
Employees547
ProvinceChong Qing Shi
Phone023-61758666-8621
Office AddressArea A, Building 2, No. 699 Maliu Avenue, Banan District, Chongqing
Zip Code401338
Registered AddressArea A, Building 2, No. 699 Maliu Avenue, Banan District, Chongqing
Fax023-61758011
Emailirm@genrixbio.com
Websitehttp://www.genrixbio.com/
Business License91500113MA5U36LJ53
BusinessThe company is an innovation-driven biopharmaceutical company. The company's main business is R&D, production and sales of antibody drugs. The products the company is developing are monoclonal antibody drugs and bispecific antibody drugs.
Company Executives
- Name
- Position
- Salary
- liwen liu
- Directors, Chief Financial Officer
- 657.70K
- zhigang liu
- Directors, Core Technical Personnel, Chief Scientific Officer
- 1.65M
- chunsheng li
- Directors, Board Secretary
- 717.60K
- rensheng jiang
- Directors
- --
- xuanlin cui
- Independent Directors
- --
- yuntong hu
- Independent Directors
- 150.00K
- li chen
- Independent Directors
- 150.00K
- yinzhen zhou
- Securities Affairs Representative
- --
- jiaqian yang
- Chairman of the Supervisory Board, Employee Representative Supervisor
- 965.10K
- hong fan
- Auditors
- --
- li dai
- Deputy General Manager, Core Technical Personnel
- 1.19M
- wei wang
- Deputy General Manager, Core Technical Personnel
- 1.17M
- wei wang
- Deputy General Manager, Core Technical Personnel
- 1.47M
- xiaoyan huang
- Deputy General Manager
- --
- xiaoli jie
- Head of the Internal Audit Department
- --
- junhua qian
- Chief Technology Officer, Core Technical Personnel
- 1.33M
- jikuan dan
- Core Technical Personnel
- 1.25M
- zhiyuan chang
- Core Technical Personnel
- 1.49M
- min kou
- Employee Representative Supervisor
- 662.80K